Antioxidants - Clinical aspects

Central European Journal of Public Health

Volumn 12, Issue SUPPL., 2004, Pages

  Hlubik P ^a   Stritecka H ^a  

^a DEPARTMENT OF TOXICOLOGY   (Czech Republic)

Author keywords

Antioxidants; Civilization diseases; Reactive oxygen species; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; FOLIC ACID; FREE RADICAL; REACTIVE OXYGEN METABOLITE; RETINOL;

ANTHROPOMETRIC PARAMETERS; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BODY MASS; CANCER; CANCER PREVENTION; CONFERENCE PAPER; DEGENERATIVE DISEASE; DRUG EFFECT; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNE SYSTEM; NEURAL TUBE DEFECT; PROPHYLAXIS; RISK FACTOR;

ANTIOXIDANTS; HUMANS; NUTRITION PHYSIOLOGY; VITAMINS;

EID: 2342505828     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Anitra C, Carr, Ben-Zhan Zhu, Frei B: Potential antiatherogenic mechanisms of ascorbate (vitamin C) and α-tocopherol (vitamin E). Circulation Res 2000; 87: 349.
2. Hlúbik P: Vitamins - important health factor - Part 2: Metabolism of hydrosoluble vitamins. Interní medicína pro praxi 2001; 3: 564-567. (In Czech.)
3. Diaz MN, Frei B et al.: Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337: 408-416.
4. Pryor WA: Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000; 28: 141-164.
5. Tröbs M, Renner T et al.: Nutrition, antioxidant, and risk factor profile of nonsmokers, passive smokers and smokers of the prevention education program (PEP) in Nuremberg, Germany. Prevent Med 2002; 34: 600-607.
6. Kalkkonen J: Supplementation with vitamin E. Free Radic Res 2001; 35: 967-978.
7. Wrieden WL, Hannah MK, Bolton-Smith C et al.: Plasma vitamin C and food choise in the third Glasgow MONICA population. J Epid Comm Hlth (England) 2000; 54: 355-360.
8. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707-727.
9. Fairfield KM, Fletcher RH: Vitamins for chronic disease prevention in adults. JAMA, 287, 2002.
10. Hlúbik P: Vitamins - important health factor - Part 1: Metabolism of liposoluble vitamins. Interní medicina pro praxi 2001; 3: 503-505. (In Czech.)
11. Janaszewska A, Bartosz G: Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma. Scand J Clin Lab Invest 2002; 62: 231-236.
12. Prior RL, Cao G: In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 1999; 27: 1173-1181.
13. Rice-Evans CA: Measurement of total antioxidant activity as a marker of antioxidant status in vivo: procedure and limitations. Free Radic Res 2000; 33: S59-S66.
14. Ghiselli A, Serafini M, Natella F, Scaccini C: Total antioxidant capacity as tool to assess redox status: critical view and experimental data. Free Radic Biol Med 2000; 29: 1106-1114.
15. Duthie GG: Determination of activity of antioxidants. Proc Nutr Soc 1999; 58: 1015-24.
16. Strube M, Haenen GRMM, Van Den Berg H, Bast A: Pitfalls in a method for assessment of total antioxidant capacity. Free Radic Res 1997; 26: 515-521.
17. Schofield D, Braganza JM: Shortcomings of an automated assay for total antioxidant status in biological fluids. Clin Chem 1996; 42: 1712-1714.